Table 1 The clinical information for CCRCC and CHRCC patients
Sample_ID | Gender | Age (years) | BMI | Tumor size (cm) | TNM stage | Fuhrman grade |
|---|---|---|---|---|---|---|
CCRCC group | ||||||
CCRCC-1 | Male | 52 | 24.06 | 3 | T1a | I |
CCRCC-2 | Male | 46 | 26.23 | 1.5 | T1a | I–II |
CCRCC-3 | Male | 50 | 23.31 | 5.5 | T1b | I–II |
CCRCC-4 | Female | 39 | 21.89 | 6 | T1b | II |
CCRCC-5 | Female | 45 | 24.84 | 3 | T1a | I–II |
CHRCC group | ||||||
CHRCC-1 | Female | 46 | 28.05 | 20 | T2 | NA |
CHRCC-2 | Male | 56 | 21.35 | 4 | T1b | NA |
CHRCC-3 | Female | 20 | 16.02 | 5 | T1b | NA |
CHRCC-4 | Male | 51 | 20.38 | 2.4 | T1a | NA |
CHRCC-5 | Male | 62 | 22.41 | 12 | T2 | NA |